Middle East Pharmaceutical Industries Company SJSC Relative Valuation - Middle East Pharmaceutical Industries Company SJSC

Watchlist Manager

Watchlist

Price: 121.2 SAR 1.68%

Market Cap: 2.4B SAR

Section:

Relative Value

The Relative Value of one Middle East Pharmaceutical Industries Company SJSC stock under the Base Case scenario is hidden SAR. Compared to the current market price of 121.2 SAR, Middle East Pharmaceutical Industries Company SJSC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

Middle East Pharmaceutical Industries Company SJSC Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

4.1

P/S

vs History	50
vs Industry	26

Median 5Y

4.1

Industry

2.4

Forward

6.2

More Details

P/E

vs History	50
vs Industry	17

Median 5Y

Industry

20.5

Forward

27.6

More Details

32.3

P/OCF

vs History	7
vs Industry	21

Median 5Y

32.4

Industry

15.4

More Details

73.3

P/FCFE

vs History	28
vs Industry	10

Median 5Y

73.3

Industry

22.6

More Details

7.4

P/B

vs History	35
vs Industry	8

Median 5Y

7.4

Industry

More Details

4.2

EV/S

vs History	50
vs Industry	24

Median 5Y

4.2

Industry

2.5

Forward

6.3

More Details

6.8

EV/GP

vs History	50
vs Industry	24

Median 5Y

6.8

Industry

4.9

More Details

17.8

EV/EBITDA

vs History	50
vs Industry	18

Median 5Y

17.8

Industry

12.6

Forward

22.5

More Details

20.3

EV/EBIT

vs History	50
vs Industry	19

Median 5Y

20.3

Industry

15.6

Forward

25.1

More Details

33.1

EV/OCF

vs History	7
vs Industry	22

Median 5Y

33.1

Industry

13.9

More Details

62.7

EV/FCFF

vs History	0
vs Industry	15

Median 5Y

58.9

Industry

17.7

More Details

5.7

EV/IC

vs History	50
vs Industry	14

Median 5Y

5.7

Industry

1.8

More Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
SA	M	Middle East Pharmaceutical Industries Company SJSC SAU:4016	2.4B SAR	4.1	24	17.8	20.3
US		Eli Lilly and Co NYSE:LLY	819.5B USD	18.2	77.4	44.9	49.6
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	578.3	-15 783.5	3 846.3	17 702.3
US		Johnson & Johnson NYSE:JNJ	393B USD	4.4	27.9	13.1	17.2
DK		Novo Nordisk A/S CSE:NOVO B	2.3T DKK	8	22.9	15.1	17.1
CH		Roche Holding AG SIX:ROG	242.5B CHF	4.1	21.1	11.7	13.9
US		Merck & Co Inc NYSE:MRK	233.7B USD	3.6	13.7	9.2	10.9
UK		AstraZeneca PLC LSE:AZN	177.6B GBP	4.2	32.6	126.9	193.9
CH		Novartis AG SIX:NOVN	199.6B CHF	4.4	18.9	11.4	14.7
IE	E	Endo International PLC LSE:0Y5F	166.1B USD	71.6	-56.8	265.3	665.3
US		Pfizer Inc NYSE:PFE	148.1B USD	2.3	18.4	8.7	12.5

				Revenue Growth	P/S to Growth
SA	M	Middle East Pharmaceutical Industries Company SJSC SAU:4016	Average P/S: 63.9 4.1	15%	0.3
US		Eli Lilly and Co NYSE:LLY	18.2	22%	0.8
UK		Dechra Pharmaceuticals PLC LSE:DPH	578.3	9%	64.3
US		Johnson & Johnson NYSE:JNJ	4.4	3%	1.5
DK		Novo Nordisk A/S CSE:NOVO B	8	17%	0.5
CH		Roche Holding AG SIX:ROG	4.1	5%	0.8
US		Merck & Co Inc NYSE:MRK	3.6	5%	0.7
UK		AstraZeneca PLC LSE:AZN	4.2	7%	0.6
CH		Novartis AG SIX:NOVN	4.4	3%	1.5
IE	E	Endo International PLC LSE:0Y5F	71.6	N/A	N/A
US		Pfizer Inc NYSE:PFE	2.3	0%	N/A

				Earnings Growth	PEG
SA	M	Middle East Pharmaceutical Industries Company SJSC SAU:4016	Average P/E: 28.6 24	24%	1
US		Eli Lilly and Co NYSE:LLY	77.4	48%	1.6
UK		Dechra Pharmaceuticals PLC LSE:DPH	Negative Multiple: -15 783.5	N/A	N/A
US		Johnson & Johnson NYSE:JNJ	27.9	26%	1.1
DK		Novo Nordisk A/S CSE:NOVO B	22.9	19%	1.2
CH		Roche Holding AG SIX:ROG	21.1	16%	1.3
US		Merck & Co Inc NYSE:MRK	13.7	17%	0.8
UK		AstraZeneca PLC LSE:AZN	32.6	36%	0.9
CH		Novartis AG SIX:NOVN	18.9	16%	1.2
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -56.8	N/A	N/A
US		Pfizer Inc NYSE:PFE	18.4	29%	0.6

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

P	Peijia Medical Ltd HKEX:9996	4.8 HKD -0.21%
	Nomura Research Institute Ltd TSE:4307	4 887 JPY -0.83%
	Daiseki Co Ltd TSE:9793	3 850 JPY -0.9%
	Torii Pharmaceutical Co Ltd TSE:4551	4 760 JPY 0.63%
C	Carlit Holdings Co Ltd TSE:4275	1 110 JPY -0.54%
	Godawari Power and Ispat Ltd NSE:GPIL	184.94 INR -1.03%

	Franklin Covey Co NYSE:FC	28.65 USD 0.56%
	Mohawk Industries Inc NYSE:MHK	116.5 USD 4.14%
	Ardmore Shipping Corp NYSE:ASC	10.15 USD 1.4%
	ASGN Inc NYSE:ASGN	63.73 USD 0.11%
	Skyworks Solutions Inc NASDAQ:SWKS	69.02 USD 2.63%
	Weatherford International PLC NASDAQ:WFRD	53.87 USD 3.14%

	Johnson & Johnson NYSE:JNJ	163.29 USD -0.21%
	Bank of America Corp NYSE:BAC	43.07 USD 1.41%
	Mastercard Inc NYSE:MA	543.67 USD 1.49%
	Salesforce Inc NYSE:CRM	285.96 USD 1.9%
	Abbvie Inc NYSE:ABBV	209.17 USD -0.4%
	Home Depot Inc NYSE:HD	363.77 USD 3.59%

	Arista Networks Inc NYSE:ANET	87.51 USD 5.27%
	Visa Inc NYSE:V	343.87 USD 2.45%
	Texas Pacific Land Corp NYSE:TPL	1 344.98 USD 5.64%
	KLA Corp NASDAQ:KLAC	727.73 USD 3.01%
	Manhattan Associates Inc NASDAQ:MANH	177.97 USD 4.03%
	Monolithic Power Systems Inc NASDAQ:MPWR	627.93 USD 6.25%

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
Middle East Pharmaceutical Industries Company SJSC Competitors

See Also

Company

Help

Tools

Stocks

				EBITDA Growth	EV/EBITDA to Growth
SA	M	Middle East Pharmaceutical Industries Company SJSC SAU:4016	Average EV/EBITDA: 397.3 17.8	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	44.9	30%	1.5
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	36%	106.8
US		Johnson & Johnson NYSE:JNJ	13.1	7%	1.9
DK		Novo Nordisk A/S CSE:NOVO B	15.1	15%	1
CH		Roche Holding AG SIX:ROG	11.7	8%	1.5
US		Merck & Co Inc NYSE:MRK	9.2	9%	1
UK		AstraZeneca PLC LSE:AZN	126.9	9%	14.1
CH		Novartis AG SIX:NOVN	11.4	5%	2.3
IE	E	Endo International PLC LSE:0Y5F	265.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	8.7	3%	2.9

				EBIT Growth	EV/EBIT to Growth
SA	M	Middle East Pharmaceutical Industries Company SJSC SAU:4016	Average EV/EBIT: 1 701.6 20.3	21%	1
US		Eli Lilly and Co NYSE:LLY	49.6	33%	1.5
UK		Dechra Pharmaceuticals PLC LSE:DPH	17 702.3	98%	180.6
US		Johnson & Johnson NYSE:JNJ	17.2	12%	1.4
DK		Novo Nordisk A/S CSE:NOVO B	17.1	16%	1.1
CH		Roche Holding AG SIX:ROG	13.9	9%	1.5
US		Merck & Co Inc NYSE:MRK	10.9	12%	0.9
UK		AstraZeneca PLC LSE:AZN	193.9	21%	9.2
CH		Novartis AG SIX:NOVN	14.7	8%	1.8
IE	E	Endo International PLC LSE:0Y5F	665.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	12.5	10%	1.2

	ServiceNow Inc NYSE:NOW	849.73 USD 2.66%
	EOG Resources Inc NYSE:EOG	128.27 USD 2.48%
	Monster Beverage Corp NASDAQ:MNST	57.83 USD 0.91%
	Applied Materials Inc NASDAQ:AMAT	154.95 USD 1.86%
	Airbnb Inc NASDAQ:ABNB	129.82 USD 0.79%
	Synopsys Inc NASDAQ:SNPS	457.77 USD 2.04%

52 Week Range	112.4 177
Price Target

Middle East Pharmaceutical Industries Company SJSC SAU:4016

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples Middle East Pharmaceutical Industries Company SJSC Competitors

See Also

Company

Help

Tools

Stocks

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Competitors Multiples
Middle East Pharmaceutical Industries Company SJSC Competitors